Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Evolent Health Inc has a consensus price target of $33.71 based on the ratings of 17 analysts. The high is $59 issued by Cowen & Co. on January 30, 2023. The low is $15 issued by JP Morgan on November 22, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Oppenheimer, and Citigroup on November 22, 2024, November 18, 2024, and November 13, 2024, respectively. With an average price target of $21.33 between JP Morgan, Oppenheimer, and Citigroup, there's an implied 87.96% upside for Evolent Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Evolent Health (NYSE:EVH) was reported by JP Morgan on November 22, 2024. The analyst firm set a price target for $15.00 expecting EVH to rise to within 12 months (a possible 32.16% upside). 24 analyst firms have reported ratings in the last year.
The latest analyst rating for Evolent Health (NYSE:EVH) was provided by JP Morgan, and Evolent Health maintained their overweight rating.
The last upgrade for Evolent Health Inc happened on August 9, 2024 when Truist Securities raised their price target to $33. Truist Securities previously had a hold for Evolent Health Inc.
The last downgrade for Evolent Health Inc happened on November 8, 2024 when Stephens & Co. changed their price target from N/A to $16 for Evolent Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evolent Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evolent Health was filed on November 22, 2024 so you should expect the next rating to be made available sometime around November 22, 2025.
While ratings are subjective and will change, the latest Evolent Health (EVH) rating was a maintained with a price target of $45.00 to $15.00. The current price Evolent Health (EVH) is trading at is $11.35, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.